secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001193125-25-016455
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics raises $10M in registered direct offering of shares and warrants
--------------------------------------------------------------------------------

- Gross proceeds of $10.0M from sale of 1,261,830 shares and warrants priced at $7.925 per unit.
- Warrants exercisable at $7.80/share for five years, immediately exercisable with 4.99% ownership blocker.
- H.C. Wainwright & Co. acted as exclusive placement agent; net proceeds for working capital and general corporate purposes.
- Offering closed on January 30, 2025 under effective shelf registration statement (File No. 333-279925).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/0001193125-25-016455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/d914999d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-016455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer